Trials / Completed
CompletedNCT02492880
CoverEdge Algorithm Programming Study
Study to Characterize the Effects of Programming Features of the Boston Scientific Precision Spectra™ Spinal Cord Stimulator System Using the CoverEdge™ Surgical Leads
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, on-label, multi-center, non-randomized, exploratory, single-arm study to characterize the effects of programming features of the Boston Scientific Precision Spectra™ Spinal Cord Stimulator (SCS) System using the CoverEdge™ surgical lead.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Precision Spectra™ SCS system programming features | Precision Spectra™ SCS system programming features using the CoverEdge surgical lead. |
Timeline
- Start date
- 2015-07-20
- Primary completion
- 2017-02-21
- Completion
- 2017-02-21
- First posted
- 2015-07-09
- Last updated
- 2022-11-04
- Results posted
- 2018-08-07
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02492880. Inclusion in this directory is not an endorsement.